Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.

Abstract

More than 1/3 of all non-small cell lung carcinoma (NSCLC) patients present with locally advanced non-metastatic disease. Despite radiation therapy and surgery the survival of these patients remains poor. In an effort to improve upon these results 33 clinical Stage III M0 patients from April 1985 through September 1986 were entered into a Phase II study at… (More)

Topics

Cite this paper

@article{Pincus1988PreoperativeCM, title={Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.}, author={Michael Pincus and Sushanth Reddy and Myung Sik Lee and Philip D. Bonomi and Steven G Taylor and Kendrith M. Rowland and L Penfield Faber and William Warren and C F Kittle and Frank R Hendrickson}, journal={International journal of radiation oncology, biology, physics}, year={1988}, volume={15 1}, pages={189-95} }